Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial
(1) Background: The incidence of gestational diabetes mellitus (GDM) is rising globally. The current evidence indicates that GDM, especially in conjunction with maternal overweight, can alter the composition of infants’ gut microbiota, potentially increasing the risk of inflammatory diseases, metabo...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/13/1/112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832587865995870208 |
|---|---|
| author | Gayatri Athalye-Jape Chandra Prakash Rath Harshad Panchal Archita Mishra Dorothy Graham Sanjay Patole |
| author_facet | Gayatri Athalye-Jape Chandra Prakash Rath Harshad Panchal Archita Mishra Dorothy Graham Sanjay Patole |
| author_sort | Gayatri Athalye-Jape |
| collection | DOAJ |
| description | (1) Background: The incidence of gestational diabetes mellitus (GDM) is rising globally. The current evidence indicates that GDM, especially in conjunction with maternal overweight, can alter the composition of infants’ gut microbiota, potentially increasing the risk of inflammatory diseases, metabolic disorders, and neurodevelopmental issues later in life. Probiotic supplantation early in life might establish eubiosis and mitigate future complications. To best of our knowledge, no study has evaluated the effects of probiotics on gut dysbiosis in the infants of mothers with GDM. (2) Methods: This study will be a single-centre, double-blind, randomized, placebo-controlled trial enrolling sixty neonates born after 35 weeks of gestation to mothers with GDM. The participants will be randomly assigned to receive either a triple-strain probiotic or a placebo for four months. The primary objective is to assess the effectiveness of probiotic supplementation in correcting gut dysbiosis in the infants of mothers with GDM at four months of age. Faecal microbiome composition shall be estimated using 16SrRNA and shotgun sequencing. The secondary outcomes will include the quantification of faecal short-chain fatty acids at birth and at four months, as well as growth and developmental assessments at four, twelve, and twenty-four months. (3) Trial registration: This trial protocol is registered (ACTRN12624000930583p) in the Australian Clinical Trials registry (ANZCTR). |
| format | Article |
| id | doaj-art-8dcea3da5baa42958fc46f4f2cc5be13 |
| institution | Kabale University |
| issn | 2076-2607 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Microorganisms |
| spelling | doaj-art-8dcea3da5baa42958fc46f4f2cc5be132025-01-24T13:42:41ZengMDPI AGMicroorganisms2076-26072025-01-0113111210.3390/microorganisms13010112Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized TrialGayatri Athalye-Jape0Chandra Prakash Rath1Harshad Panchal2Archita Mishra3Dorothy Graham4Sanjay Patole5Department of Neonatology, King Edward Memorial Hospital, Perth, WA 6008, AustraliaDepartment of Neonatology, King Edward Memorial Hospital, Perth, WA 6008, AustraliaDepartment of Neonatology, King Edward Memorial Hospital, Perth, WA 6008, AustraliaThe Kids Research Institute, Perth, WA 6009, AustraliaDepartment of Obstetric Medicine, King Edward Memorial Hospital, Perth, WA 6008, AustraliaDepartment of Neonatology, King Edward Memorial Hospital, Perth, WA 6008, Australia(1) Background: The incidence of gestational diabetes mellitus (GDM) is rising globally. The current evidence indicates that GDM, especially in conjunction with maternal overweight, can alter the composition of infants’ gut microbiota, potentially increasing the risk of inflammatory diseases, metabolic disorders, and neurodevelopmental issues later in life. Probiotic supplantation early in life might establish eubiosis and mitigate future complications. To best of our knowledge, no study has evaluated the effects of probiotics on gut dysbiosis in the infants of mothers with GDM. (2) Methods: This study will be a single-centre, double-blind, randomized, placebo-controlled trial enrolling sixty neonates born after 35 weeks of gestation to mothers with GDM. The participants will be randomly assigned to receive either a triple-strain probiotic or a placebo for four months. The primary objective is to assess the effectiveness of probiotic supplementation in correcting gut dysbiosis in the infants of mothers with GDM at four months of age. Faecal microbiome composition shall be estimated using 16SrRNA and shotgun sequencing. The secondary outcomes will include the quantification of faecal short-chain fatty acids at birth and at four months, as well as growth and developmental assessments at four, twelve, and twenty-four months. (3) Trial registration: This trial protocol is registered (ACTRN12624000930583p) in the Australian Clinical Trials registry (ANZCTR).https://www.mdpi.com/2076-2607/13/1/112probioticsinfants of diabetic mothersgestational diabetesmicrobiome |
| spellingShingle | Gayatri Athalye-Jape Chandra Prakash Rath Harshad Panchal Archita Mishra Dorothy Graham Sanjay Patole Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial Microorganisms probiotics infants of diabetic mothers gestational diabetes microbiome |
| title | Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial |
| title_full | Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial |
| title_fullStr | Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial |
| title_full_unstemmed | Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial |
| title_short | Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial |
| title_sort | evaluation of faecal microbiota following probiotics in infants of mothers with gestational diabetes mellitus trial protocol for double blind placebo controlled randomized trial |
| topic | probiotics infants of diabetic mothers gestational diabetes microbiome |
| url | https://www.mdpi.com/2076-2607/13/1/112 |
| work_keys_str_mv | AT gayatriathalyejape evaluationoffaecalmicrobiotafollowingprobioticsininfantsofmotherswithgestationaldiabetesmellitustrialprotocolfordoubleblindplacebocontrolledrandomizedtrial AT chandraprakashrath evaluationoffaecalmicrobiotafollowingprobioticsininfantsofmotherswithgestationaldiabetesmellitustrialprotocolfordoubleblindplacebocontrolledrandomizedtrial AT harshadpanchal evaluationoffaecalmicrobiotafollowingprobioticsininfantsofmotherswithgestationaldiabetesmellitustrialprotocolfordoubleblindplacebocontrolledrandomizedtrial AT architamishra evaluationoffaecalmicrobiotafollowingprobioticsininfantsofmotherswithgestationaldiabetesmellitustrialprotocolfordoubleblindplacebocontrolledrandomizedtrial AT dorothygraham evaluationoffaecalmicrobiotafollowingprobioticsininfantsofmotherswithgestationaldiabetesmellitustrialprotocolfordoubleblindplacebocontrolledrandomizedtrial AT sanjaypatole evaluationoffaecalmicrobiotafollowingprobioticsininfantsofmotherswithgestationaldiabetesmellitustrialprotocolfordoubleblindplacebocontrolledrandomizedtrial |